Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Sashegyi
P1.13-30 Neutrophil-To-Lymphocyte Ratio as a Prognostic Factor and Its Relationship to NSCLC Patient Outcomes in the REVEL Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Neutrophil‐to‐lymphocyte Ratio as a Prognostic Factor in Advanced Stage Ovarian Carcinoma Treated With Neoadjuvant Chemotherapy
International Journal of Gynecology and Obstetrics
Medicine
Gynecology
Obstetrics
Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients With NSCLC
Materia Socio Medica
Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio for Renal Outcomes in Patients With Rapidly Progressive Glomerulonephritis
Journal of Clinical Medicine
Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Bone Metastases
British Journal of Cancer
Cancer Research
Oncology
Exploring the Prognostic Value of the Neutrophil-To-Lymphocyte Ratio in Cancer
Scientific Reports
Multidisciplinary
Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison Between the Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Prognostic Significance of Neutrophil-To-Lymphocyte Ratio in Rectal Cancer: A Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Reply to Neutrophil-To-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710
Cancer
Cancer Research
Oncology
The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy
Przeglad Gastroenterologiczny
Gastroenterology
